Non-Invasive Drug Delivery Device market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Non-Invasive Drug Delivery Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Liquid-Based Needle-Free Injector
Powder-Based Needle-Free Injector
Segment by Application
Diabetes Management
Vaccine Management
Pain Management
Respiratory Management
Others
By Company
Novartis AG
Inovio Pharmaceuticals, Inc.
Medtronic Plc.
Tandem Diabetes Care, Inc.
Teva Pharmaceutical Industries Ltd.
Crossject Medical Technology
Adherium Ltd.
Sensirion AG
Diabeloop
PharmaJet
PenJet
Portal Instruments
Capsule Technologies
Propeller Health
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
